Active infection or chronic infection requiring chronic suppressive antibiotics
Active infection requiring treatment with antibiotics
Patients must not have a serious intercurrent illness, including ongoing or active infection requiring parental antibiotics
Active uncontrolled infection; patients with infection under active treatment and controlled with antibiotics are not excluded
Active infection or chronic infection requiring chronic suppressive antibiotics.
Active infection requiring IV antibiotics at day  of cycle 
Active infection requiring IV antibiotics within  weeks of study dose
No active infection requiring antibiotics
Patients with active infection requiring antibiotics are not eligible (with the exception of uncomplicated UTI and uncomplicated respiratory tract infections)
Patients should be free of active infection requiring antibiotics (with the exception of uncomplicated urinary tract infection [UTI])
Active infection requiring antibiotics
Active infection requiring iv antibiotics at day  of cycle 
Patients who are otherwise ineligible to receive the antibiotics in this study
EXCLUSION - PROCUREMENT: Active infection requiring antibiotics
The patient has any ongoing or active infection, including active tuberculosis; Note: a urinary tract infection controlled with oral antibiotics initiated at least  days prior to study entry is acceptable
Active, uncontrolled infection; patients with infection under active treatment and controlled with antibiotics are eligible
Active infection requiring IV antibiotics on Cycle , Day 
Patients with active infection will not be eligible, but may become eligible once infection has resolved and they are at least  days from completion of antibiotics
Patients should not have any evidence of active or uncontrolled infection requiring treatment with antibiotics
Currently using antibiotics and/or anti fungal agent (however, topical antibiotics are permitted).
=<  days before first dose of protocol-indicated treatment:\r\n* Anti-cancer therapy with an approved or investigational agent (including chemotherapy, hormonal therapy, targeted therapy, immunotherapy, or biological therapy).\r\n* Radiosurgery or radiotherapy. (Note: A tumor lesion situated in a previously irradiated area is considered a measurable/target lesion only if subsequent disease progression has been documented in the lesion.)\r\n* Initiation of a new erythropoietin, darbepoietin, and/or bisphosphonate therapy.\r\n* Minor surgery. (Note: Placement of a vascular access device is not considered minor or major surgery.)\r\n* Serious or uncontrolled infection.\r\n* Infection requiring parenteral antibiotics. (Note: Patients with a non-serious infection under active treatment and controlled with oral antibiotics initiated at least  days prior to initiation of protocol-indicated treatment are not excluded  e.g. urinary tract infection controlled with oral antibiotics.)\r\n* Unexplained fever > . degree Celsius (C).
Active infection requiring systemic antibiotics or antifungals within  days prior to first dose of study drug; exception: tetracycline family antibiotics (tetracycline, doxycycline, minocycline) administered for the management of cetuximab-related rash may be continued per the investigators judgment
Active infection requiring the use of systemic antibiotics
Participant has an active infection requiring IV antibiotics
Active infection requiring systemic antibiotics within  weeks prior to cycle , day ; prophylactic short-term antibiotics will be allowed
Patients should be free of active infection requiring antibiotics (with the exception of uncomplicated urinary tract infection [UTI])
Active infection requiring antibiotics (with the exception of uncomplicated urinary tract infection)
Within  days before first dose of protocol-indicated treatment:\r\n* Active uncontrolled infection; patients with infection under active treatment and controlled with antibiotics initiated at least  days prior to initiation of protocol-indicated treatment are not excluded (e.g. urinary tract infection controlled with antibiotics)
Has an active infection requiring systemic therapy with IV antibiotics
Presence of an serious illness, uncontrolled illness, or active infection requiring IV antibiotics.
Active infection or chronic infection requiring chronic suppressive antibiotics
Have active infection requiring antibiotics
Has an active infection requiring systemic antibiotics within  days of registration
Patients should not be on antibiotics for any infection but post operative antibiotics are allowed if used prophylactically but should be completed prior to starting RT
Patients should be free of active infection requiring antibiotics (with the exception of uncomplicated urinary tract infection [UTI])
Patients with active infection will not be eligible, but may become eligible once infection has resolved and at least  days have relapsed after antibiotics use was completed
Known HIV- or any active infection requiring IV antibiotics
Has active, serious infection requiring systemic therapy. Patients may receive prophylactic antibiotics and antiviral therapy at the discretion of the treating physician.
Active infection requiring IV antibiotics  days before enrollment
Patients should be free of active infection requiring antibiotics
Active infection requiring systemic therapy with IV antibiotics
Active infection or chronic infection requiring chronic suppressive antibiotics.
Active, clinically significant serious infection requiring treatment with antibiotics, anti-virals or anti-fungals.
Active infection requiring antibiotics
Active clinically significant infection requiring antibiotics
Active infection requiring antibiotics
Active infection or chronic infection requiring chronic suppressive antibiotics.
Treated with antibiotics for infection within one week prior to study entry.
Active, clinically significant serious infection requiring treatment with antibiotics, anti-virals or anti-fungals.
Serious active infection not controlled by antibiotics
Subjects with an active infection requiring antibiotics or at an increased risk of latent infection that may affect safe study participation
Subjects with active infection requiring IV antibiotics within  weeks of study enrollment (day ) are excluded
Active, uncontrolled infection; patients with infection under active treatment and controlled with antibiotics are eligible
Active infection-must be afebrile and off antibiotics
Participants with an active infection requiring antibiotics are excluded (a positive screening urinalysis may be repeated)
Active, clinically significant serious infection requiring treatment with antibiotics, anti-virals or anti-fungals
Active, uncontrolled infection; patients with infection under active treatment and controlled with antibiotics are eligible
Uncontrolled infection requiring active treatment (systemic antibiotics, anti-virals, or anti-fungals) within  days
Any active infection not controlled by antibiotics
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment unless the patient is felt to have fully recovered and any antibiotics that are continued are either beta lactam antibiotics or are specifically allowed on study
Active infection or chronic infection requiring chronic suppressive antibiotics
Patients should be free of active infection requiring antibiotics (with the exception of uncomplicated urinary tract infection [UTI])
Patients with any unstable medical issue (including cardiac issues as above, active treatment for pulmonary embolism, cerebrovascular accident [CVA], renal or hepatic insufficiency, active infection/sepsis requiring IV antibiotics)
Evidence of any active infection requiring hospitalization or IV antibiotics within  weeks prior to study enrolment.
Patients should be free of active infection requiring antibiotics (with the exception of an uncomplicated urinary tract infection [UTI])
Active infection, or chronic infection requiring chronic suppressive antibiotics.
Active pulmonary infection not responsive to conventional antibiotics
Any known HIV infection or AIDS or any concurrent infection requiring IV antibiotics
Has an active infection requiring systemic antibiotics within  days of registration
Active infection or antibiotics within  hours prior to study
Active infection within the  days prior to randomization requiring systemic antibiotics
Presence of active infection within  hours of treatment; patients with ongoing use of prophylactic antibiotics are eligible as long as there is no evidence of active infection and the antibiotic is not included on the list of prohibited medications
Active infection requiring treatment with IV antibiotics or hospitalized for treatment of an active infection in  wks prior to starting dose of AMG .
Presence of acute active infection requiring antibiotics
Serious active infection requiring i.v. antibiotics and/or hospitalization at study entry
Patients with an active infection requiring antibiotics
Patients should be free of active infection requiring antibiotics
Uncontrolled infection requiring ongoing antibiotics
Patients with active infection will not be eligible, but may become eligible once infection has resolved and they are at least  days from completion of antibiotics
Current severe, uncontrolled systemic disease including an ongoing, active infection requiring treatment with antibiotics
Active infection involving IV antibiotics within  weeks prior to CD
Active infection involving IV antibiotics within  weeks prior to CD
Active clinically significant infection requiring antibiotics
Patients should not have any evidence of active or uncontrolled infection requiring treatment with antibiotics
Has an active infection requiring antibiotics
Ongoing or active infection requiring parental antibiotics on Day 
Known active infection requiring antibiotics within  days of the start of treatment (day )
Patients should be free of active infection requiring antibiotics (with the exception of uncomplicated urinary tract infection [UTI])
No active infection requiring antibiotics (with the exception of uncomplicated urinary tract infection)
Ongoing or active infection requiring IV antibiotics
Active infection requiring antibiotics
Has an active infection requiring systemic antibiotics.
Active infection requiring antibiotics
Ongoing or active infection requiring antibiotics;
Has an active infection requiring systemic antibiotics
Active infection requiring IV antibiotics
Infection not controlled by antibiotics
Active infection requiring antibiotics
Active, clinically significant serious infection requiring treatment with antibiotics, anti-virals or anti-fungals. The Medical Monitor should be contacted for any uncertainties.
Active, clinically significant serious infection requiring treatment with antibiotics, anti-virals, or anti-fungals.
Active infection requiring antibiotics
Active infection requiring antibiotics
Active infection requiring IV antibiotics within  weeks prior to screening
Active infection requiring iv antibiotics
Presence of an acute infection requiring antibiotics within  weeks of study entry or a chronic infection including but not limited to: urinary tract infection, HIV, viral hepatitis
Has uncontrolled infection requiring systematic antibiotics
Active infection requiring (IV) antibiotics within  weeks of study enrollment
Active infection requiring IV antibiotics
Any infection requiring antibiotics within the past  weeks.
Serious infection requiring antibiotics
Pneumonia requiring antibiotics at the time of study enrollment
Patients with a previous or current line infection are ineligible until  days after the completion of antibiotics
Infection not controlled by antibiotics
Active infection requiring antibiotics
No use of antibiotics in the previous  months; or current regular use of antibiotics
Patients should be free of active infection requiring antibiotics
A non?urologic bacterial infection requiring active treatment with antibiotics
Patients with active and/or uncontrolled infections or who are still recovering from an infection\r\n* Actively febrile patients with uncertain etiology of febrile episode\r\n* All antibiotics should be completed at least  week ( days) prior to collection\r\n* No recurrence of fever or other symptoms related to infection for at least  week ( days) following completion of antibiotics\r\n* Note: Use of antibiotics for pre-operative prophylaxis is not an exclusion
The participant has an active infection (requiring I.V antibiotics), including tuberculosis.
Known active infection requiring antibiotics within  days of initiation of study treatment, unless considered controlled in the opinion of the investigator